Australia - China BioInnovation Roundtable
This closed door event will explore economic opportunities for Australia and China in the biotech and healthcare industries, particularly in light of the US Congress passing the Biosecure Act—a measure aimed at securing critical biotech supply chains and reducing foreign influence. The event will focus on key themes such as:
The role of cross-border education programs in fostering biotech talent
Attracting venture capital and government investment for startups
Navigating complex trade regulations
Building resilient supply chains
Driving innovation through research collaborations
Industry leaders, policymakers, and academics will discuss how Australia and China can deepen their partnership to thrive in this rapidly evolving global landscape.
A limited number of in-person participation slots available in Melbourne CBD.